哈尔滨三联药业股份有限公司关于全资子公司变更经营范围并完成工商变更登记的公告

Core Viewpoint - Harbin Sanlian Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary, Harbin Longjiang Animal Health Biotechnology Co., Ltd., has changed its business scope and completed the registration with the industrial and commercial authorities, obtaining a new business license [1]. Group 1: Business Scope Change - The business scope of Harbin Longjiang Animal Health Biotechnology Co., Ltd. has been updated to include "Internet sales (excluding goods that require permits)" and "food internet sales (only for pre-packaged food)" [1]. - The previous business scope included various activities such as veterinary drug production, veterinary drug operation, and feed additive production, which remain unchanged in the new scope [1]. Group 2: Regulatory Compliance - The company confirmed that all other registration details in the business license remain unchanged, ensuring compliance with relevant regulatory requirements [1].